Global Metagenomics Sequencing Market 2022 - Industry Briefing

November 2022 | 44 pages | ID: GD5C7215ED68EN
Gen Consulting Company

Abstracts

According to Gen Consulting Company, the global metagenomics sequencing market size is expected to increase from USD 902 million in 2021 to USD 2,299 million by 2028, garnering a CAGR of 14.3% over the evaluated period.

This industry report offers market estimates of the global market, followed by a detailed analysis of the component, technology, end user, and region. The global market data on metagenomics sequencing can be segmented by component: instruments, reagents & consumables, services. The services segment was the largest contributor to the global metagenomics sequencing market in 2021. Metagenomics sequencing market is further segmented by technology: shotgun metagenomic sequencing, whole genome sequencing & de novo assembly, metatranscriptomics, 16S rRNA sequencing. According to the research, the shotgun metagenomic sequencing segment had the largest share in the global metagenomics sequencing market. Based on end user, the metagenomics sequencing market is segmented into: drug discovery, ecology & environmental metagenomics, clinical diagnostics, industrial, others. The drug discovery segment held the largest revenue share in 2021. On the basis of region, the metagenomics sequencing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global metagenomics sequencing market is highly competitive. The key players in the metagenomics sequencing market include Azenta Inc. (Genewiz), BGI Group Ltd., DNAStar Inc., Eurofins Scientific SE, Illumina Inc., Macrogen Inc., Microsynth AG, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, PerkinElmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corporation.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Metagenomics Sequencing Market
• Identify segments/areas to invest in over the forecast period in the Global Metagenomics Sequencing Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. METAGENOMICS SEQUENCING MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY COMPONENT

Instruments
Reagents & consumables
Services

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Shotgun metagenomic sequencing
Whole genome sequencing & de novo assembly
Metatranscriptomics
16S rRNA sequencing

PART 6. MARKET BREAKDOWN BY END USER

Drug discovery
Ecology & environmental metagenomics
Clinical diagnostics
Industrial
Others

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Azenta, Inc. (Genewiz)
BGI Group Ltd.
DNAStar, Inc.
Eurofins Scientific SE
Illumina, Inc.
Macrogen, Inc.
Microsynth AG
Novogene Co., Ltd.
Oxford Nanopore Technologies Limited
PerkinElmer, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
Zymo Research Corporation

PART 9. METHODOLOGY